Transcription of MOH CLINICAL PRACTICE GUIDELINES 2/2016
{{id}} {{{paragraph}}}
Example: dental hygienist
MOH CLINICAL PRACTICE GUIDELINES 2/2016
1 MOH CLINICAL PRACTICE GUIDELINES 2/2016 LIPIDSEXECUTIVE SUMMARYC hapter of Family Medicine PhysiciansAcademy of Medicine, SingaporeCollege of Family Physicians, SingaporeSingapore Cardiac SocietyChapter of EndocrinologistsChapter of General PhysiciansCollege of Physicians, SingaporeEndocrine & Metabolic Society of SingaporeContents PageIntroduction and how to use this document 2 Lipids in coronary artery disease 4 Classification & screening for dyslipidemia 4 Risk assessment of CAD in dyslipidemia 6 Target lipid levels 8 Lifestyle changes 10 Drug therapy 12 Special considerations 16 Quality indicators for lipid management 19 Levels of evidence and grades of recommendation 262 EXECUTIVE SUMMARY OF RECOMMENDATIONS IntroductionThis is the executive summary of the MOH CLINICAL PRACTICE GUIDELINES (CPG) on Lipids.
• HDL High density lipoprotein • HMG-CoA 3-hydroxy-3-methyl-glutaryl-CoA • IDL Intermediate density lipoprotein • LDL Low density lipoprotein • Lp(a) Lipoprotein(a) ... The steps taken for risk stratification are illustrated in Figure 1. First, very high risk and high risk patients can be identified based on whether they have existing ...
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: